Skip to main content
. 2022 Jun 13;12(1):61–72. doi: 10.1002/cam4.4937

FIGURE 2.

FIGURE 2

Mean differences in covariates between patients with advanced hepatocellular carcinoma receiving lenvatinib plus idarubicin‐loaded DEB‐TACE or lenvatinib alone before and after propensity score‐matching analysis. Abbreviations: AFP, alpha‐fetoprotein; ECOG, Eastern Cooperative Oncology Group (performance status); EHS, extrahepatic spread; HBV, hepatitis B virus; VI, vascular invasion.